Showing results (1341-1350 of 4,882) with videos related to

Sort By:
Pageof 489
Urologic Oncology|January 2, 2022
Oncologic outcomes of organ-confined Gleason grade group 4-5 prostate cancer after radical prostatectomyFelix Preisser, Nuowei Wang, Raisa S Abrams-Pompe, et al.
Urologic Oncology|March 26, 2021
Systemic dissemination of tumor cells during transurethral resection in patients with bladder tumor and its clinical relevance: A follow up studyRishi Nayyar, Sumit Saini, Alpana Sharma, et al.
Urologic Oncology|March 26, 2021
Cost-effectiveness analysis of neoadjuvant immune checkpoint inhibition vs. cisplatin-based chemotherapy in muscle invasive bladder cancerAli Raza Khaki, Yong Shan, Richard E Nelson, et al.
Urologic Oncology|March 7, 2021
Multiparametric MRI with in-bore targeted biopsy in the diagnostic pathway of prostate cancer: Data from a single institution experienceGeorges Nawfal, Julien Sarkis, Sarah Assaf, et al.
Urologic Oncology|October 22, 2022
Analysis of sex-based differences to Bacillus Calmette-Guérin for non-muscle invasive bladder cancerJonathan Fadel, David Simonyan, Vincent Fradet, et al.
Urologic Oncology|November 1, 2022
A population-based evaluation of tunica vaginalis mesothelioma: An analysis of the National Cancer DatabaseHunter D D Witmer, Ankit Dhiman, Mihai Giurcanu, et al.
Urologic Oncology|November 1, 2022
5α-reductase inhibitors and the risk of bladder cancer in a large, population-based cohortSnir Dekalo, Eric McArthur, Jeffrey Campbell, et al.
Urologic Oncology|October 16, 2022
Efficacy of cabazitaxel in fourth or later line of therapy in metastatic castration-resistant prostate cancer: Multi-institutional real-world experience in GermanyMike Wenzel, Angelika Borkowetz, Verena Lieb, et al.
Urologic Oncology|November 3, 2022
Alternative Complement Pathway Signature Determines Immunosuppression and Resistance to Immunotherapy Plus Tyrosine Kinase Inhibitor Combinations in Renal Cell CarcinomaJiajun Wang, Sihong Zhang, Ying Wang, et al.
Urologic Oncology|October 24, 2022
Prognostic Value of Sarcopenia and Albumin in the Surgical Management of Localized Renal Cell CarcinomaEric Midenberg, Michelle I Higgins, Benjamin N Schmeusser, et al.
Pageof 489